Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Repare Therapeutics Inc. RPTX

Set alert

Price alert · RPTX

All alert types
2.65 USD 0.00 0.00%

At close · Jan 28

2.64 -0.01 -0.37%

After hours · Jan 28, 4:00 PM ET

Bid
2.64 × 2
Ask
2.65 × 2
2.65 Day range 2.65

52-week range unavailable

YTD
+1.92%
1 year
+130.43%
Open
2.65
Prev close
2.65
Mkt cap
57.39M
Vol
1.17M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
2.65
High
2.65
Forward P/E
-0.45
Beta
0.71
Short ratio
4.57
Inst. own
83.62%
Dividend
0.00
Ex-div date
Earnings
Aug 6, 2024
50-d avg
3.10
200-d avg
3.47
1y target
8.50

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for RPTX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-0.08 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.7×
FY 2017: -62.9×FY 2018: -34.2×FY 2019: -41.6×FY 2020: -23.7×FY 2021: -7.5×FY 2022: -21.3×FY 2023: -3.3×FY 2024: -0.7×
FY 2017 5y median -7.5× FY 2024
P/S 1.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 9376×FY 2021: 105×FY 2022: 4.7×FY 2023: 6.0×FY 2024: 1.0×
FY 2017 5y median 6.0× FY 2024
P/B 0.4×
FY 2017: 0.0×FY 2018: -21.7×FY 2019: 12.6×FY 2020: 4.4×FY 2021: 2.8×FY 2022: 2.2×FY 2023: 1.4×FY 2024: 0.4×
FY 2017 5y median 2.2× FY 2024
P/FCF -0.7×
FY 2017: -67.9×FY 2018: -36.8×FY 2019: -57.2×FY 2020: -152×FY 2021: -9.1×FY 2022: -2202×FY 2023: -2.4×FY 2024: -0.7×
FY 2017 5y median -9.1× FY 2024
EV/EBITDA 0.3×
FY 2017: 0.0×FY 2018: -35.4×FY 2019: -40.1×FY 2020: -17.7×FY 2021: -4.4×FY 2022: -26.0×FY 2023: -1.7×FY 2024: 0.3×
FY 2017 5y median -4.4× FY 2024
EV/Sales -0.5×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 6990×FY 2021: 61.9×FY 2022: 3.5×FY 2023: 3.9×FY 2024: -0.5×
FY 2017 5y median 3.9× FY 2024
FCF Yield -137.6%
FY 2017: -1.5%FY 2018: -2.7%FY 2019: -1.7%FY 2020: -0.7%FY 2021: -11.0%FY 2022: -0.0%FY 2023: -42.0%FY 2024: -137.6%
FY 2017 5y median -11.0% FY 2024

Profitability

Gross Margin 75.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -28622.2%FY 2021: -1056.0%FY 2022: 11.5%FY 2023: 74.1%FY 2024: 75.0%
FY 2017 5y median 11.5% FY 2024
Operating Margin -174.9%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -40223.7%FY 2021: -1429.7%FY 2022: -15.0%FY 2023: -227.3%FY 2024: -174.9%
FY 2017 5y median -227.3% FY 2024
Net Margin -158.4%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -39568.1%FY 2021: -1406.7%FY 2022: -22.0%FY 2023: -183.4%FY 2024: -158.4%
FY 2017 5y median -183.4% FY 2024
ROE -56.0%
FY 2017: 0.0%FY 2018: 63.8%FY 2019: -30.3%FY 2020: -18.6%FY 2021: -37.1%FY 2022: -10.4%FY 2023: -44.2%FY 2024: -56.0%
FY 2017 5y median -37.1% FY 2024
ROIC -61.1%
FY 2017: 0.0%FY 2018: -106.7%FY 2019: -26.1%FY 2020: -15.3%FY 2021: -31.9%FY 2022: -6.9%FY 2023: -48.6%FY 2024: -61.1%
FY 2017 5y median -31.9% FY 2024
ROA -48.0%
FY 2017: 0.0%FY 2018: -102.6%FY 2019: -26.5%FY 2020: -15.0%FY 2021: -29.0%FY 2022: -8.0%FY 2023: -36.9%FY 2024: -48.0%
FY 2017 5y median -29.0% FY 2024

Growth (YoY)

Revenue 4.6%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 5529.6%FY 2022: 1634.6%FY 2023: -61.2%FY 2024: 4.6%
FY 2017 FY 2024
Operating Income 19.5%
FY 2017: 0.0%FY 2018: -107.6%FY 2019: -101.3%FY 2020: -110.4%FY 2021: -100.1%FY 2022: 81.8%FY 2023: -487.1%FY 2024: 19.5%
FY 2017 FY 2024
EPS (diluted) 10.3%
FY 2017: 0.0%FY 2018: -83.7%FY 2019: 17.8%FY 2020: -95.9%FY 2021: -95.2%FY 2022: 75.6%FY 2023: -223.2%FY 2024: 10.3%
FY 2017 FY 2024
Free Cash Flow 40.8%
FY 2017: 0.0%FY 2018: -84.3%FY 2019: -49.5%FY 2020: 57.8%FY 2021: -951.4%FY 2022: 99.7%FY 2023: -46005.7%FY 2024: 40.8%
FY 2017 FY 2024

Financial Health

Current Ratio 6.8×
FY 2017: 0.0×FY 2018: 6.3×FY 2019: 23.2×FY 2020: 31.5×FY 2021: 10.0×FY 2022: 4.5×FY 2023: 6.2×FY 2024: 6.8×
FY 2017 5y median 6.8× FY 2024
Quick Ratio 6.8×
FY 2017: 0.0×FY 2018: 6.3×FY 2019: 23.2×FY 2020: 31.5×FY 2021: 10.0×FY 2022: 4.5×FY 2023: 6.2×FY 2024: 6.8×
FY 2017 5y median 6.8× FY 2024
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: -0.1×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2017 5y median 0.0× FY 2024
Net Debt / EBITDA 0.9×
FY 2017: 0.0×FY 2018: 0.6×FY 2019: 3.6×FY 2020: 6.0×FY 2021: 3.1×FY 2022: 8.6×FY 2023: 0.9×FY 2024: 0.9×
FY 2017 5y median 3.1× FY 2024
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2017 5y median 0.0× FY 2024

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2017 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2017 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31